Date: 2014-07-21
Type of information: Company acquisition
Acquired company: Platine Pharma Services (France)
Acquiring company: Advanced BioScience Laboratories (ABL) (USA - MD), part of the Institut Mérieux
Amount: undisclosed
Terms: * On July 21, 2014, Advanced BioScience Laboratories (ABL), a Maryland-based biomedical contract research and manufacturing organization to the biopharmaceutical industry, has announced the acquisition of a majority interest in Platine Pharma Services (Platine), a specialist in immunomonitoring and immunogenicity services. “This acquisition also represents a significant step in the strategic growth of ABL, providing a European-based facility for clinical and other sample processing and immunomonitoring analyses, Dr. Thomas VanCott, President and CEO of ABL, commented.
Details: Platine Pharma is a specialist in immunomonitoring and immunogenicity services with laboratories located in Lyon. The company helps clients in the biopharmaceutical, food, cosmetic and diagnostic industries evaluate the immunogenicity, activity and efficacy of products during R&D, preclinical and human clinical studies. Platine provides immunologic expertise and services using a broad range of in vitro platforms such as flow cytometry, ELISpot, ELISA, multiplex, Singulex™, and MSD® capabilities. Platine also offers its Immuno’line™ T-cell activation service, a unique approach to assess the specific immune response to a particular therapeutic drug, vaccine, cosmetic, or food product of interest. ABL is dedicated to advancing vaccines, therapeutics and other biologic products. Its services include basic research, product design, process and assay development, preclinical studies, clinical immunomonitoring and immunogenicity testing, and Phase I/II cGMP biologics manufacturing. Since 2001, ABL has been a part of the Institut Mérieux.
Related: CRO Technology - Services Immunology
